Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ahmed AK Hassoun, Md Faruque Pathan, Rita C Medlej, Monira Alarouj, Inass Shaltout, Manoj S Chawla, Ditte Knap & Julius A Vaz. (2016) Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study. Diabetes, Metabolic Syndrome and Obesity 9, pages 225-231.
Read now
Read now
Mohamed Hassanein, Khalifa Abdallah & Anja Schweizer. (2014) A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study. Vascular Health and Risk Management 10, pages 319-326.
Read now
Read now
Articles from other publishers (3)
Mahmoud Ibrahim, Mary Moffett Barker, Ehtasham Ahmad, Asma Ahmed, Firas A. Annabi, Ebtesam M. Ba‐Essa, Melanie J. Davies, Pamela Houeiss, Hinde Iraqi, Shabeen Naz Masood, Safia Mimouni‐Zerguini, Shehla Shaikh, Hyam Tantawi & Jaakko Tuomilehto. (2023) Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus. Diabetes/Metabolism Research and Reviews 39:3.
Crossref
Crossref
Rashmi Shiju, Ayesha Akhil, Smitha Thankachan, Jaakko Tuomilehto, Monira Al Arouj & Abdullah Bennakhi. (2022) Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis. Journal of Diabetes Research 2022, pages 1-11.
Crossref
Crossref
Ehab Mudher Mikhael. (2016) Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients. Journal of Diabetes Research 2016, pages 1-10.
Crossref
Crossref